Investigational CD19-directed CAR T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational CD19-directed CAR T-cell therapy, covering 2024-05-30 to 2024-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy Using CAR T-cells to Target CD19 for Relapsed/Refractory CD19+ Primary CNS Lymphoma [Phase 1]